EMA and FDA unveil joint AI principles to transform drug revelopment
Experts caution that realizing AI’s potential requires careful management and risk mitigation
Experts caution that realizing AI’s potential requires careful management and risk mitigation
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
The partnership will launch a Phase 1b cohort within Boehringer’s ongoing Beamion-BCGC1 trial
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
Developed using STEERLife’s proprietary FragMelt continuous processing platform, the approval marks a major breakthrough in pharmaceutical manufacturing
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
Subscribe To Our Newsletter & Stay Updated